| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.28B | 18.89B | 17.34B | 11.90B | 6.58B | 7.54B |
| Gross Profit | 11.90B | 12.52B | 11.11B | 8.74B | 4.78B | 5.65B |
| EBITDA | 4.37B | 4.44B | 3.52B | 2.91B | 839.95M | 1.56B |
| Net Income | 2.45B | 2.31B | 1.97B | 1.55B | -146.01M | 723.40M |
Balance Sheet | ||||||
| Total Assets | 41.24B | 41.96B | 37.78B | 31.72B | 25.03B | 21.51B |
| Cash, Cash Equivalents and Short-Term Investments | 13.44B | 12.30B | 11.17B | 9.41B | 6.71B | 5.57B |
| Total Debt | 5.31B | 5.41B | 5.01B | 3.01B | 2.41B | 329.39M |
| Total Liabilities | 19.03B | 18.38B | 16.81B | 13.17B | 9.04B | 6.25B |
| Stockholders Equity | 21.22B | 22.56B | 20.00B | 17.70B | 15.73B | 15.22B |
Cash Flow | ||||||
| Free Cash Flow | 4.46B | 3.75B | 2.57B | 3.03B | -230.70M | 1.53B |
| Operating Cash Flow | 4.71B | 4.31B | 2.97B | 4.00B | 302.31M | 1.84B |
| Investing Cash Flow | -4.97B | -4.70B | -834.26M | -1.76B | -397.03M | -1.56B |
| Financing Cash Flow | -226.09M | -1.09B | 678.79M | -592.23M | 1.54B | -20.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$275.44B | 10.09 | 20.98% | 0.41% | 17.19% | 94.71% | |
67 Neutral | HK$41.79B | 20.14 | 10.95% | 0.79% | 11.93% | 19.19% | |
66 Neutral | HK$93.30M | -57.07 | 0.79% | 4.55% | 32.99% | -94.85% | |
64 Neutral | HK$248.71M | 7.16 | 34.76% | 12.00% | -7.39% | -50.92% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | HK$426.43M | 20.99 | 12.44% | ― | -1.97% | -57.63% | |
46 Neutral | HK$294.53M | -1.89 | -70.20% | ― | 9.11% | 5.66% |